Ucb Sa Stock Today
| UCBJF Stock | USD 174.00 1.00 0.57% |
Performance0 of 100
| Odds Of DistressLess than 11
|
UCB SA is trading at 174.00 as of the 22nd of November 2024. This is a 0.57% down since the beginning of the trading day. The stock's lowest day price was 174.0. UCB SA has less than a 11 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. Equity ratings for UCB SA are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 23rd of October 2024 and ending today, the 22nd of November 2024. Click here to learn more.
UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases. The company was incorporated in 1925 and is headquartered in Brussels, Belgium. Ucb SA operates under Biotechnology classification in the United States and is traded on OTC Exchange. The company has 189.96 M outstanding shares. More on UCB SA
Moving against UCB Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
UCB Pink Sheet Highlights
| Chairman | JeanChristophe Tellier |
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
UCB SA [UCBJF] is a Pink Sheet which is traded between independent brokers as part of over-the-counter (OTC) trading. The company currently falls under 'Large-Cap' category with a current market capitalization of 15.88 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate UCB SA's market, we take the total number of its shares issued and multiply it by UCB SA's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. UCB SA classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 189.96 M outstanding shares.
UCB SA has accumulated about 515 M in cash with 1.55 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.71.
Check UCB SA Probability Of Bankruptcy
Ownership AllocationUCB SA secures a total of 189.96 Million outstanding shares. UCB SA shows substantial amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company retains, if the real value of the entity is less than the current market value, you may not be able to make money on it.
Check UCB Ownership Details
UCB SA Risk Profiles
| Mean Deviation | 0.4747 | |||
| Standard Deviation | 1.71 | |||
| Variance | 2.92 | |||
| Risk Adjusted Performance | 0.032 |
UCB Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in UCB SA without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Comparator Now
Portfolio ComparatorCompare the composition, asset allocations and performance of any two portfolios in your account |
| All Next | Launch Module |
UCB SA Corporate Management
| Sandrine CFA | Ex CFO | Profile | |
| William Silbey | Exec Counsel | Profile | |
| Pr LowFriedrich | Chief VP | Profile | |
| Kirsten LundJurgensen | Ex Solutions | Profile | |
| Caroline Vancoillie | Chief Functions | Profile |
Other Information on Investing in UCB Pink Sheet
UCB SA financial ratios help investors to determine whether UCB Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in UCB with respect to the benefits of owning UCB SA security.